Dolby Depreciation And Amortization vs Selling And Marketing Expenses Analysis

DLB Stock

USD 80.25 1.73 2.11%

Dolby Laboratories financial indicator trend analysis is much more than just examining Dolby Laboratories latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dolby Laboratories is a good investment. Please check the relationship between Dolby Laboratories Depreciation And Amortization and its Selling And Marketing Expenses accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.

Depreciation And Amortization vs Selling And Marketing Expenses

Depreciation And Amortization vs Selling And Marketing Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dolby Laboratories Depreciation And Amortization account and Selling And Marketing Expenses. At this time, the significance of the direction appears to have strong relationship.

The correlation between Dolby Laboratories' Depreciation And Amortization and Selling And Marketing Expenses is 0.63. Overlapping area represents the amount of variation of Depreciation And Amortization that can explain the historical movement of Selling And Marketing Expenses in the same time period over historical financial statements of Dolby Laboratories, assuming nothing else is changed. The correlation between historical values of Dolby Laboratories' Depreciation And Amortization and Selling And Marketing Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation And Amortization of Dolby Laboratories are associated (or correlated) with its Selling And Marketing Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling And Marketing Expenses has no effect on the direction of Depreciation And Amortization i.e., Dolby Laboratories' Depreciation And Amortization and Selling And Marketing Expenses go up and down completely randomly.

Correlation Coefficient

0.63

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Selling And Marketing Expenses

Most indicators from Dolby Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dolby Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.At present, Dolby Laboratories' Issuance Of Capital Stock is projected to decrease significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.22, whereas Selling General Administrative is forecasted to decline to about 191.1 M.

	2021	2022	2023	2024 (projected)
Gross Profit	1.1B	892.2M	1.1B	790.3M
Total Revenue	1.3B	1.0B	1.3B	860.5M

Gross Profit Total Revenue

Dolby Laboratories fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Total Current Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Good Will	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab
Total Assets		1.0	-0.78	0.79	0.77	0.45	0.92	0.42	0.67	0.89	0.79	0.94	0.69	1.0	0.43	0.92	0.56	0.68	0.72	0.9	0.49	0.86	0.72	0.17	-0.13	0.91
Total Stockholder Equity	1.0		-0.8	0.8	0.8	0.5	0.92	0.48	0.63	0.84	0.77	0.93	0.67	1.0	0.42	0.91	0.51	0.64	0.69	0.88	0.51	0.82	0.68	0.14	-0.09	0.87
Net Debt	-0.78	-0.8		-0.99	-0.96	-0.49	-0.89	-0.57	-0.32	-0.54	-0.65	-0.81	-0.22	-0.79	-0.3	-0.54	-0.29	-0.3	-0.58	-0.59	-0.26	-0.67	-0.34	0.18	-0.03	-0.63
Cash	0.79	0.8	-0.99		0.95	0.51	0.92	0.48	0.4	0.57	0.63	0.82	0.22	0.8	0.34	0.54	0.39	0.39	0.63	0.61	0.29	0.7	0.36	-0.08	-0.05	0.66
Cash And Short Term Investments	0.77	0.8	-0.96	0.95		0.66	0.89	0.6	0.34	0.49	0.57	0.75	0.25	0.78	0.37	0.53	0.26	0.3	0.5	0.55	0.33	0.57	0.35	-0.16	0.06	0.56
Common Stock Shares Outstanding	0.45	0.5	-0.49	0.51	0.66		0.49	0.53	0.39	0.15	0.25	0.32	0.29	0.47	0.54	0.36	0.2	0.28	0.02	0.36	0.74	0.14	0.16	0.22	0.2	0.16
Total Current Assets	0.92	0.92	-0.89	0.92	0.89	0.49		0.38	0.6	0.79	0.68	0.88	0.46	0.93	0.38	0.7	0.55	0.55	0.8	0.79	0.35	0.79	0.58	0.08	-0.25	0.82
Short Long Term Debt Total	0.42	0.48	-0.57	0.48	0.6	0.53	0.38		-0.19	0.05	0.29	0.34	0.18	0.46	0.01	0.39	-0.34	-0.24	-0.1	0.36	0.33	0.11	0.03	-0.47	0.46	0.09
Other Current Liab	0.67	0.63	-0.32	0.4	0.34	0.39	0.6	-0.19		0.81	0.59	0.57	0.67	0.63	0.66	0.66	0.9	0.93	0.59	0.68	0.62	0.68	0.72	0.75	-0.33	0.78
Total Current Liabilities	0.89	0.84	-0.54	0.57	0.49	0.15	0.79	0.05	0.81		0.76	0.81	0.77	0.85	0.47	0.85	0.72	0.79	0.8	0.83	0.37	0.87	0.82	0.35	-0.35	0.98
Other Liab	0.79	0.77	-0.65	0.63	0.57	0.25	0.68	0.29	0.59	0.76		0.84	0.56	0.77	0.42	0.78	0.55	0.6	0.57	0.77	0.34	0.91	0.81	0.12	0.08	0.85
Property Plant And Equipment Net	0.94	0.93	-0.81	0.82	0.75	0.32	0.88	0.34	0.57	0.81	0.84		0.49	0.94	0.34	0.85	0.54	0.67	0.77	0.82	0.31	0.92	0.68	0.06	-0.1	0.89
Current Deferred Revenue	0.69	0.67	-0.22	0.22	0.25	0.29	0.46	0.18	0.67	0.77	0.56	0.49		0.66	0.49	0.81	0.46	0.61	0.33	0.66	0.58	0.54	0.72	0.41	-0.14	0.69
Retained Earnings	1.0	1.0	-0.79	0.8	0.78	0.47	0.93	0.46	0.63	0.85	0.77	0.94	0.66		0.4	0.91	0.52	0.64	0.72	0.89	0.48	0.83	0.69	0.13	-0.13	0.88
Accounts Payable	0.43	0.42	-0.3	0.34	0.37	0.54	0.38	0.01	0.66	0.47	0.42	0.34	0.49	0.4		0.42	0.4	0.58	0.16	0.26	0.57	0.33	0.36	0.43	0.0	0.43
Non Current Assets Total	0.92	0.91	-0.54	0.54	0.53	0.36	0.7	0.39	0.66	0.85	0.78	0.85	0.81	0.91	0.42		0.5	0.71	0.54	0.86	0.58	0.79	0.75	0.26	0.01	0.85
Non Currrent Assets Other	0.56	0.51	-0.29	0.39	0.26	0.2	0.55	-0.34	0.9	0.72	0.55	0.54	0.46	0.52	0.4	0.5		0.86	0.69	0.67	0.39	0.73	0.72	0.72	-0.53	0.74
Other Assets	0.68	0.64	-0.3	0.39	0.3	0.28	0.55	-0.24	0.93	0.79	0.6	0.67	0.61	0.64	0.58	0.71	0.86		0.63	0.64	0.5	0.74	0.72	0.67	-0.33	0.79
Net Receivables	0.72	0.69	-0.58	0.63	0.5	0.02	0.8	-0.1	0.59	0.8	0.57	0.77	0.33	0.72	0.16	0.54	0.69	0.63		0.7	-0.02	0.79	0.61	0.14	-0.62	0.83
Good Will	0.9	0.88	-0.59	0.61	0.55	0.36	0.79	0.36	0.68	0.83	0.77	0.82	0.66	0.89	0.26	0.86	0.67	0.64	0.7		0.51	0.83	0.8	0.28	-0.25	0.86
Common Stock Total Equity	0.49	0.51	-0.26	0.29	0.33	0.74	0.35	0.33	0.62	0.37	0.34	0.31	0.58	0.48	0.57	0.58	0.39	0.5	-0.02	0.51		0.29	0.29	0.65	0.21	0.34
Non Current Liabilities Total	0.86	0.82	-0.67	0.7	0.57	0.14	0.79	0.11	0.68	0.87	0.91	0.92	0.54	0.83	0.33	0.79	0.73	0.74	0.79	0.83	0.29		0.81	0.26	-0.2	0.95
Inventory	0.72	0.68	-0.34	0.36	0.35	0.16	0.58	0.03	0.72	0.82	0.81	0.68	0.72	0.69	0.36	0.75	0.72	0.72	0.61	0.8	0.29	0.81		0.31	-0.26	0.84
Other Current Assets	0.17	0.14	0.18	-0.08	-0.16	0.22	0.08	-0.47	0.75	0.35	0.12	0.06	0.41	0.13	0.43	0.26	0.72	0.67	0.14	0.28	0.65	0.26	0.31		-0.26	0.31
Other Stockholder Equity	-0.13	-0.09	-0.03	-0.05	0.06	0.2	-0.25	0.46	-0.33	-0.35	0.08	-0.1	-0.14	-0.13	0.0	0.01	-0.53	-0.33	-0.62	-0.25	0.21	-0.2	-0.26	-0.26		-0.3
Total Liab	0.91	0.87	-0.63	0.66	0.56	0.16	0.82	0.09	0.78	0.98	0.85	0.89	0.69	0.88	0.43	0.85	0.74	0.79	0.83	0.86	0.34	0.95	0.84	0.31	-0.3

Click cells to compare fundamentals

Dolby Laboratories Account Relationship Matchups

Dolby Laboratories fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.9B	3.1B	2.7B	3.0B	3.1B	2.0B
Total Stockholder Equity	2.4B	2.6B	2.2B	2.4B	2.5B	1.7B
Net Debt	(990.7M)	(1.2B)	(569.2M)	(694.7M)	(435.1M)	(456.8M)
Cash	1.1B	1.2B	620.1M	745.4M	482.0M	588.8M
Cash And Short Term Investments	1.1B	1.3B	809.3M	884.5M	482.0M	746.4M
Common Stock Shares Outstanding	102.9M	104.6M	102.0M	97.6M	97.3M	113.5M
Liabilities And Stockholders Equity	2.9B	3.1B	2.7B	3.0B	3.1B	2.0B
Total Current Assets	1.5B	1.8B	1.3B	1.5B	1.2B	1.0B
Other Current Liab	207.4M	244.9M	216.1M	330.5M	379.2M	398.1M
Total Current Liabilities	267.1M	315.7M	277.5M	422.2M	417.8M	228.7M
Other Liab	146.5M	129.0M	123.3M	148.3M	170.6M	93.7M
Property Plant And Equipment Net	618.5M	601.5M	560.0M	521.8M	518.2M	338.0M
Current Deferred Revenue	15.4M	18.5M	18.6M	31.5M	36.2M	20.5M
Retained Earnings	2.4B	2.6B	2.3B	2.4B	2.5B	1.6B
Accounts Payable	12.6M	17.8M	14.2M	20.9M	17.4M	23.7M
Non Current Assets Total	1.4B	1.3B	1.4B	1.5B	1.9B	1.0B
Non Currrent Assets Other	91.2M	61.3M	55.1M	94.7M	120.6M	126.6M
Other Assets	210.1M	217.3M	238.7M	296.5M	341.0M	358.1M
Net Receivables	341.7M	414.9M	419.7M	444.4M	315.5M	161.5M
Good Will	489.4M	340.7M	365.1M	408.4M	533.2M	295.2M
Non Current Liabilities Total	211.8M	185.7M	161.0M	185.4M	225.9M	115.7M
Inventory	25.6M	11.0M	23.5M	35.6M	33.7M	20.7M
Other Current Assets	53.0M	62.7M	23.2M	50.7M	363.2M	381.3M
Other Stockholder Equity	99K	406K	100K	94K	(37.0M)	89.3K
Total Liab	478.9M	501.5M	438.5M	607.6M	623.0M	343.4M
Property Plant And Equipment Gross	618.5M	601.5M	560.0M	521.8M	600.0M	326.9M
Accumulated Other Comprehensive Income	(10.6M)	(10.0M)	(51.6M)	(37.0M)	(19.2M)	(18.2M)
Short Term Debt	15.8M	15.4M	13.3M	13.6M	12.2M	12.8M
Intangible Assets	152.4M	122.9M	112.3M	167.4M	434.5M	456.2M
Property Plant Equipment	542.0M	534.4M	560.0M	521.8M	600.0M	319.4M
Short Term Investments	46.9M	38.8M	189.2M	139.1M	125.2M	138.8M
Net Tangible Assets	1.9B	2.1B	1.8B	1.8B	2.0B	1.7B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

When determining whether Dolby Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dolby Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dolby Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dolby Laboratories Stock:

How To Invest In Dolby

Details

Is Dolby Stock a good investment?

Details

What is Dolby Laboratories' Net Worth?

Details

Largest Electronic Equipment, Instruments & Components Companies

View

Largest Technology Hardware & Equipment Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dolby Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For information on how to trade Dolby Stock refer to our How to Trade Dolby Stock guide.

You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dolby Laboratories. If investors know Dolby will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dolby Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.353

Earnings Share

3.11

Revenue Per Share

13.172

Quarterly Revenue Growth

(0.03)

Return On Assets

0.0516

The market value of Dolby Laboratories is measured differently than its book value, which is the value of Dolby that is recorded on the company's balance sheet. Investors also form their own opinion of Dolby Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Dolby Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dolby Laboratories' market value can be influenced by many factors that don't directly affect Dolby Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Dolby Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dolby Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dolby Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Dolby Depreciation And Amortization vs Selling And Marketing Expenses Analysis

Depreciation And Amortization vs Selling And Marketing Expenses

Depreciation And Amortization vs Selling And Marketing Expenses Correlation Analysis

Correlation Coefficient

Depreciation And Amortization

Selling And Marketing Expenses

Dolby Laboratories fundamental ratios Correlations

Dolby Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Dolby Laboratories fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Stockholder Equity
Total Liab	+ 0.98	Total Current Liabilities
Cash And Short Term Investments	+ 0.95	Cash
Total Liab	+ 0.95	Non Current Liabilities Total

Cash	- 0.99	Net Debt
Cash And Short Term Investments	- 0.96	Net Debt
Total Current Assets	- 0.89	Net Debt
Property Plant And Equipment Net	- 0.81	Net Debt
Net Debt	- 0.8	Total Stockholder Equity
Retained Earnings	- 0.79	Net Debt